PTAB: Year in Review - 2020 (RECORDING)
2020 was a year for the record books at the Patent Trial and Appeal Board (PTAB), which saw landmark decisions at the Federal Circuit and U.S. Supreme Court, revisions to practice and procedures, as well as continued discussion on the constitutionality of PTAB judges. Seasoned practitioners and corporate counsel will discuss 2020’s major developments and how they may impact patent litigation practice going forward before the PTAB and beyond.
Specific topics will include:
Summary of key developments
Constitutionality of PTAB judges – ensuing developments on Arthrex
Non-reviewability of PTAB decisions related to institution
Discretionary denial – NHK Spring/Fintiv factors and proposed new PTAB rules
Collins Aerospace, an operating unit of Raytheon Technologies Corporation
Chris is IP Counsel for Collins Aerospace, an operating unit of Raytheon Technologies Corporation, where he is counsel for the Digital business while also coordinating consistent IP engagement with IP Counsel across the enterprise. Chris serves as Co-Chair for IPO’s U.S. Post-Grant Review Committee. For the businesses he supports Chris has led IP strategy development and execution in invention harvesting, patent procurement, and post-grant monetization/enforcement/challenge phases.
Foley & Lardner LLP
Michael is a partner and intellectual property attorney with Foley & Lardner LLP, where his practice focuses on patent challenges before the USPTO, and patent litigation at the trial and appeal levels across a wide array of technology areas. Dr. Houston has litigated patents involving pharmaceuticals, medical devices, biorenewable fuels, microelectronics fabrication and packaging, electronics, and general chemical and polymer processing, among others. More recently, Dr. Houston has been heavily involved in inter partes review (IPR) proceedings at the U.S. Patent Office, and is vice chair of the firm’s Patent Office Trials Practice.
Vice President, Associate General Counsel, Intellectual Property
Shaun is the Vice President, Associate General Counsel, IP at United Therapeutics Corporation. In that role, Shaun is responsible for UT’s intellectual property matters, including patent litigation and post-grant proceedings. Prior to joining UT, Shaun worked at two law firms initially splitting his time between patent prosecution and litigation before focusing exclusively on litigation. Shaun has experience in a variety of technology areas, including pharmaceuticals, biotechnology, medical devices, semiconductor packaging, and software.